| Dr Clifford G Allen, DPM | |
|
214 N Main St Ste 203, Sand Springs, OK 74063-7652 | |
| (918) 430-9709 | |
| Not Available |
| Full Name | Dr Clifford G Allen |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 20 Years |
| Location | 214 N Main St Ste 203, Sand Springs, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447366695 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0131X | Podiatrist - Foot Surgery | 255 (Oklahoma) | Primary |
| 213E00000X | Podiatrist | PO3473 (Florida) | Secondary |
| Provider Name | Clifford G Allen Ii Dpm Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568774867 PECOS PAC ID: 4183758949 Enrollment ID: O20100816000233 |
News Archive
A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.
The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.
In the study, which appeared on the pre-print server medRxiv*, the team also modeled the pandemic phases with exponential growth and decay. The model improves upon maximum likelihood estimates by conditioning on more data.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the European Medicines Agency has granted Advanced Therapy Medicinal Product classification for its novel stem cell drug 'Stempeucel' which will be used for the treatment of Thromboangiitis Obliterans (TAO).
› Verified 5 days ago
| Provider Name | Clifford G Allen Ii Dpm Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1568774867 PECOS PAC ID: 3173875697 Enrollment ID: O20181011001490 |
News Archive
A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.
The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.
In the study, which appeared on the pre-print server medRxiv*, the team also modeled the pandemic phases with exponential growth and decay. The model improves upon maximum likelihood estimates by conditioning on more data.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the European Medicines Agency has granted Advanced Therapy Medicinal Product classification for its novel stem cell drug 'Stempeucel' which will be used for the treatment of Thromboangiitis Obliterans (TAO).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clifford G Allen, DPM 214 N Main St, Ste 203, Sand Springs, OK 74063-7652 Ph: (918) 430-9709 | Dr Clifford G Allen, DPM 214 N Main St Ste 203, Sand Springs, OK 74063-7652 Ph: (918) 430-9709 |
News Archive
A new study used deep learning with image recognition technology to trace the emergence of variants with increased viral fitness. Higher fitness leads to rapid expansion of these lineages in the areas where they are introduced. This type of study could facilitate the development of more effective antibodies and vaccines to help contain the pandemic.
The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the disease who do not respond to conventional treatment.
In the study, which appeared on the pre-print server medRxiv*, the team also modeled the pandemic phases with exponential growth and decay. The model improves upon maximum likelihood estimates by conditioning on more data.
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the European Medicines Agency has granted Advanced Therapy Medicinal Product classification for its novel stem cell drug 'Stempeucel' which will be used for the treatment of Thromboangiitis Obliterans (TAO).
› Verified 5 days ago
Integrity Diabetic Shoes Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 117 N Garfield Ave, Sand Springs, OK 74063 Phone: 918-924-2557 |